Who owns ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED?

In the current sources, ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED is connected to Director Alan Blazei, Mr Nigel Granville Page, Director James Karis, Director Alan Blazei, ICON CLINICAL RESEARCH (U.K.) NO. 3 LIMITED and 4 more. Trace the full chain to the ultimate beneficial owner in the WhiteIntel ownership graph.

What is ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED's risk level?

WhiteIntel flags ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED appear across sources?

ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED is indexed in the WhiteIntel corporate-ownership graph (GB), with a source on every claim.

LIVE · CORPUS

SnitchScore · reading…

evidence coverage · reading…

Coverage — measured

Sources fused: 2
Ownership hops held: 21

An absent edge means not yet observed — never does not exist.

Legal entityLowActive

ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED

Name: ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED, Company, GB

ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED — active UK company, incorporated 2013 (oo:GB-COH-08630390). UBO chain traced 21 hops, 9 owners, 12 officers.…

OO GB-COH-08630390Inc. 30 Jul 2013ltdGB

Ownership graph Export .md

JSON / MCPsample

Live UK registry

The finding

Ownership resolves 21 hops deep toward the ultimate beneficial owner.

Investigative lead by resolved identity, not a legal determination.

/01

Registry identity

Status: active
Incorporated: 2013-07-30
Legal form: ltd
Activity: 86900
Registered office: 3rd Floor, North & South Wings 100 Longwater Avenue, Green Park, Reading, Berkshire, RG2 6GP, United Kingdom

/02

Ownership & control

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Owners / controllers

ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED
- Director Alan Blazei· beneficial owner· via CH PSC
- Mr Nigel Granville Page· beneficial owner· via OpenOwnership
- Director James Karis· beneficial owner· via OpenOwnership
- ICON CLINICAL RESEARCH (U.K.) NO. 3 LIMITED· beneficial owner100%· via OpenOwnership
- ICON CLINICAL RESEARCH (U.K.) LIMITED· beneficial owner87.5%· via CH PSC

Holdings / subsidiaries

None in current sources.

Walk the full UBO chain

21 hops lockedSTANDARD

21-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.

Unlock Standard Dossier€39

Standard Dossier€39

The full ownership trace on this subject — every hop to the ultimate owner, its filing history and sanctions exposure — as PDF and JSON, every claim linked to its source.

Everything we hold on ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED, resolved and sourced — yours to keep, no subscription.

INCLUDED WHEN YOU UNLOCK

UBO trace
same-address
Branded PDF + un-redacted JSON · every claim linked to its source
Re-download for 90 days

UBO trace · same-address

Guest checkout · email only · re-download 90 days. Or subscribe from €149.

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, address & registry profile
Sanctions & watchlist detail
Direct connections (1 hop)
Community notes

YOURS AFTER YOU UNLOCK · PAID

3 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.

Full ownership trace to the UBOSTANDARD
Cross-source resolution & same-addressSTANDARD
Full export (PDF + un-redacted JSON) & change alertsPREMIUM

/03

Also at this address

Shared registered office

Other companies registered at the same address — a common structuring / formation-agent signal, not proof of a link.

8 companiesSTANDARD

8 other companies at this registered office — unlock the itemised list.

Unlock Standard Dossier€39

/04

Register record, filings & financials

live · Companies House

Company no.: 08630390
Status: active
Type: ltd
Incorporated: 2013-07-30
Registered office: 3rd Floor, North & South Wings 100 Longwater Avenue, Green Park, Reading, Berkshire, RG2 6GP, United Kingdom
SIC: 86900

/05

People & control

15 parties · 3 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
FOX, Erina, Ms.
- secretary · appointed 2017-07-27 · Companies House
●
HOLMES, Simon
- director · British · appointed 2017-07-27 · Companies House
■
Icon Clinical Research (U.K.) Limited
- corporate PSC · 75–100% shares · United Kingdom · since 2025-05-31 · CH · PSC register
Also holds roles at 8 other companies
- ICON CLINICAL RESEARCH (U.K.) NO. 3 LIMITEDbeneficial owner
- VSK (KENILWORTH) LIMITEDbeneficial owner
- ICON DEVELOPMENT SOLUTIONS LIMITEDbeneficial owner
●
ANDERSON, Neil David
- director · British · appointed 2014-01-15 · resigned · Companies House
●
BERRYMAN, David Robert
- director · Us Citizen · appointed 2014-09-05 · resigned · Companies House
●
BLAZEI, Alan Steven
- director · American · appointed 2014-12-30 · resigned · Companies House
●
Director Alan Blazei
- individual PSC · significant influence or control · England · ceased 2017-07-19 · CH · PSC register
●
Director James Karis
- individual PSC · significant influence or control as trust · England · ceased 2017-07-19 · CH · PSC register
●
FORD, Stephen Kelsey
- director · British · appointed 2013-07-30 · resigned · Companies House
●
GLEESON, Michael
- director · Irish · appointed 2017-07-27 · resigned · Companies House
■
Icon Clinical Research (U.K.) No. 3 Limited
- corporate PSC · 75–100% shares · United Kingdom · ceased 2025-05-31 · CH · PSC register
Also holds roles at 6 other companies
- ICON CLINICAL RESEARCH (U.K.) LIMITEDbeneficial owner
- Mr Jean-Louis Marc Menardbeneficial owner
- Mr Bernard Marcel Jambonbeneficial owner
●
KARIS, James Michael
- director · American · appointed 2014-12-30 · resigned · Companies House
●
PAGE, Nigel Granville
- secretary · British · appointed 2014-12-30 · resigned · Companies House
- director · British · appointed 2016-08-24 · resigned · Companies House
- individual PSC · significant influence or control · England · ceased 2017-07-19 · CH · PSC register
●
SHEEHAN, Alan
- director · Irish · appointed 2017-07-27 · resigned · Companies House
●
SPICOLA, Brigid
- secretary · appointed 2013-07-30 · resigned · Companies House

15 parties · 3 current. Ceased and resigned records are retained as history.

/06

Common questions

Who owns ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED?: In the current sources, ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED is connected to Director Alan Blazei, Mr Nigel Granville Page, Director James Karis, Director Alan Blazei, ICON CLINICAL RESEARCH (U.K.) NO. 3 LIMITED and 4 more. Trace the full chain to the ultimate beneficial owner in the WhiteIntel ownership graph.
What is ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED's risk level?: WhiteIntel flags ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED appear across sources?: ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED is indexed in the WhiteIntel corporate-ownership graph (GB), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…